Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Christopher M. Bearden"'
Publikováno v:
Journal of Immunological Methods. 300:192-199
Both monoclonal (e.g. Orthoclone (OKT3), rituximab) and polyclonal (e.g. ATGAM, Thymoglobulin (Thymo)) anti-lymphocyte Abs (ALAs) are used extensively in organ transplantation for immunosuppression induction, desensitization, and treatment of acute r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fee83e456b916e153d10fd37cbaaf25
https://doi.org/10.1016/j.jim.2005.03.001
https://doi.org/10.1016/j.jim.2005.03.001
Autor:
Mark D. Pescovitz, Benita K. Book, Richard A. Sidner, Christopher M. Bearden, Avinash Agarwal, Carlos A. Vieira
Publikováno v:
Human Antibodies. 13:55-62
Rituximab, chimeric anti-human CD20 monoclonal antibody approved for B-cell lymphoma, depletes circulating B cells. Little data exist on its use for nonmalignant diseases or B-cell subset recovery after treatment. We hypothesized that rituximab may r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6b66d884a002123ef0665db82c75fd1
https://doi.org/10.3233/hab-2004-13301
https://doi.org/10.3233/hab-2004-13301
Autor:
Mark D. Pescovitz, Timothy Taber, Michael A. Kraus, Carlos A. Vieira, Christopher M. Bearden, Naomi S. Fineberg, R A Sidner, Howard M. Gebel, Anthony L. Roggero, Benita K. Book, Avinash Agarwal
Publikováno v:
Transplantation. 77:542-548
Background Preformed HLA antibodies (Ab), reported as panel-reactive antibody (PRA), prolong patient waiting time for kidney transplantation. We hypothesized that rituximab (RTX) could reduce PRA via B-cell depletion. This initial study reports the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5347ac0f9759cfbf9346f38714702c2f
https://doi.org/10.1097/01.tp.0000112934.12622.2b
https://doi.org/10.1097/01.tp.0000112934.12622.2b
Autor:
Kevin A. Thomas, Mitchel B. Harris, Daniel J. Gallagher, Christopher M. Bearden, M Alan Hinton
Publikováno v:
Orthopedics. 20:51-57
A tibial shaft fracture model was created to study the effects of an intramedullary nail and partial fibulectomy on fracture loading. Cadaveric lower extremities were instrumented with strain gages and subjected to biomechanical testing. A nonreamed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06336c1af067d380d548dba793dc98c2
https://doi.org/10.3928/0147-7447-19970101-11
https://doi.org/10.3928/0147-7447-19970101-11
The Effect of Anterior Thoracolumbar Plate Application on the Compressive Loading of the Strut Graft
Publikováno v:
Spine. 21:1487-1493
Study Design In vitro biomechanical testing was performed using a simulated vertebral body bone graft instrumented with strain gauges. Strains were recorded from various locations on the graft during axial compressive loading. Comparisons were made o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b34861a091731e45924e99c2d116dc
https://doi.org/10.1097/00007632-199607010-00001
https://doi.org/10.1097/00007632-199607010-00001
Autor:
A.B. Milgrom, Nancy G. Higgins, Christopher M. Bearden, Mark D. Pescovitz, R A Sidner, Benita K. Book, Avinash Agarwal
Publikováno v:
Transplantation proceedings. 37(2)
Humanized and chimeric antilymphocyte antibodies (Ab) are used to prevent and treat rejection and for treatment of human disease. Rituximab (RIT, anti-CD20), daclizumab (DAC; anti-CD25), alemtuzumab (ALE; anti-CD52), or infliximab (IFX) may interfere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7aed657422daeb7965763ac847c1d75
https://pubmed.ncbi.nlm.nih.gov/15848485
https://pubmed.ncbi.nlm.nih.gov/15848485
Autor:
Marquerite Young, Mark D. Pescovitz, Carlos A. Vieira, Christopher M. Bearden, R A Sidner, Benita K. Book, Avinash Agarwal, Hans D. Ochs
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 5(1)
The response to primary immunization in patients treated with Rituximab (RIT) is not clear. We studied the in vivo antibody response of chronic renal failure (CRF) patients to the neoantigen bacteriophage phiX174 given alone or after ablation with RI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e87035d8ff2db37890fcd211f157c07
https://pubmed.ncbi.nlm.nih.gov/15636611
https://pubmed.ncbi.nlm.nih.gov/15636611
Autor:
Richard A, Sidner, Benita K, Book, Avinash, Agarwal, Christopher M, Bearden, Carlos A, Vieira, Mark D, Pescovitz
Publikováno v:
Human antibodies. 13(3)
Rituximab, chimeric anti-human CD20 monoclonal antibody approved for B-cell lymphoma, depletes circulating B cells. Little data exist on its use for nonmalignant diseases or B-cell subset recovery after treatment. We hypothesized that rituximab may r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::14d8340615549cda059859dd2bb3bc19
https://pubmed.ncbi.nlm.nih.gov/15598985
https://pubmed.ncbi.nlm.nih.gov/15598985
Autor:
Howard M. Gebel, Mark D. Pescovitz, Christopher M. Bearden, Benita K. Book, Avinash Agarwal, R A Sidner, Robert A. Bray
Publikováno v:
Human immunology. 65(8)
Rituximab (RIT), a murine/human chimeric monoclonal antibody directed against human CD20 is under investigation for its role in transplantation. RIT causes B-cell crossmatches to appear positive. Pronase, a proteolytic enzyme that targets F(c) recept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eda0c03fc433ce628101b11d2c22a87
https://pubmed.ncbi.nlm.nih.gov/15336781
https://pubmed.ncbi.nlm.nih.gov/15336781
Autor:
Mark D. Pescovitz, R A Sidner, Nancy G. Higgins, Benita K. Book, Avinash Agarwal, Christopher M. Bearden
Publikováno v:
Transplantation. 78:191
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6ee586bf7f2a252d8a31f1c36cb382d
https://doi.org/10.1097/00007890-200407271-00499
https://doi.org/10.1097/00007890-200407271-00499